[1]
Ranki, A. et al. 2011. Molecular Markers Associated with Clinical Response to Bexarotene Therapy in Cutaneous T-cell Lymphoma. Acta Dermato-Venereologica. 91, 5 (Apr. 2011), 568–573. DOI:https://doi.org/10.2340/00015555-1114.